Walleye Capital’s Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share HIPO.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding HIPO.WS
CAC
SPC
KL
SRF
LCG
GS
Walleye Capital's HIPO.WS Position: Q4 2023 in Review
Walleye Capital sold out of Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share (HIPO.WS) in Q4 2023, closing a stake of 134,411 shares — an estimated $2.58K sold.
Walleye Capital first reported a position in HIPO.WS in Q2 2022 and held it in 6 quarters. The position peaked at $18K in Q3 2022. 19 funds tracked by Wall St. Rank hold HIPO.WS as of Q4 2023.
- Walleye Capital reported no remaining Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share position as of Q4 2023 after selling out during the quarter.
- Walleye Capital sold 134,411 Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share shares in Q4 2023, an estimated $2.58K.
- Walleye Capital first reported a position in Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share in Q2 2022 and held it in 6 quarters.
- Walleye Capital's Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share position peaked at $18K in Q3 2022.
- 19 funds tracked by Wall St. Rank held Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share as of Q4 2023.
Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.